NEUARTIGE PEPTIDE UND KOMBINATION AUS PEPTIDEN ZUR VERWENDUNG IN DER IMMUNTHERAPIE GEGEN OVARIALKARZINOM UND ANDERE KARZINOME

NEUARTIGE PEPTIDE UND KOMBINATION AUS PEPTIDEN ZUR VERWENDUNG IN DER IMMUNTHERAPIE GEGEN OVARIALKARZINOM UND ANDERE KARZINOME

Provided is a peptide of up to 30 amino acids comprising the amino acid sequence of SEQ ID NO: 217 or one of SEQ ID NOs: 1 to 10, 12 to 216 and 218 to 640. Provided are inter alia also a nucleic acid encoding such peptide, a host cell comprising the same, a T-cell receptor reactive with such peptide...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: FRITSCHE, Jens, MAHR, Andrea, WEINSCHENK, Toni, HÖRZER, Helen, SINGH, Harpreet, SCHOOR, Oliver
Format: Patent
Sprache:fre
Schlagworte:
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Provided is a peptide of up to 30 amino acids comprising the amino acid sequence of SEQ ID NO: 217 or one of SEQ ID NOs: 1 to 10, 12 to 216 and 218 to 640. Provided are inter alia also a nucleic acid encoding such peptide, a host cell comprising the same, a T-cell receptor reactive with such peptide and an activated T lymphocyte recognizing a cell which presents such peptide. Provided is also the use of any of the above in cancer treatment.